Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Update

Henry Schein, Inc. (NASDAQ:HSIC) saw a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 5,374,661 shares, a growth of 28.9% from the February 26th total of 4,168,764 shares. Based on an average daily volume of 1,379,464 shares, the short-interest ratio is presently 3.9 days. Currently, 4.7% of the company’s stock are short sold.

Insiders Place Their Bets

In other news, Director Philip A. Laskawy sold 2,844 shares of the business’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $80.36, for a total value of $228,543.84. Following the sale, the director owned 21,961 shares of the company’s stock, valued at $1,764,785.96. The trade was a 11.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kurt P. Kuehn sold 2,844 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $78.96, for a total transaction of $224,562.24. Following the transaction, the director owned 15,420 shares of the company’s stock, valued at $1,217,563.20. The trade was a 15.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 105,911 shares of company stock valued at $8,574,982 over the last 90 days. 1.14% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Henry Schein

Institutional investors have recently modified their holdings of the business. CYBER HORNET ETFs LLC bought a new stake in shares of Henry Schein during the 2nd quarter worth $25,000. MUFG Securities EMEA plc bought a new position in shares of Henry Schein in the second quarter worth about $27,000. Flagship Harbor Advisors LLC acquired a new stake in shares of Henry Schein in the 4th quarter valued at approximately $30,000. Federated Hermes Inc. bought a new stake in shares of Henry Schein during the 4th quarter valued at approximately $32,000. Finally, Los Angeles Capital Management LLC bought a new stake in shares of Henry Schein during the 4th quarter valued at approximately $37,000. Institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HSIC. Barrington Research set a $97.00 target price on Henry Schein and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Robert W. Baird set a $100.00 price target on Henry Schein and gave the company an “outperform” rating in a research note on Monday, February 23rd. Mizuho boosted their price target on Henry Schein from $81.00 to $88.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a report on Monday, December 29th. Finally, Wells Fargo & Company raised their target price on shares of Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 25th. Six investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus target price of $85.58.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded up $1.00 during mid-day trading on Tuesday, reaching $73.70. 1,033,411 shares of the company were exchanged, compared to its average volume of 1,375,882. The stock has a market capitalization of $8.45 billion, a P/E ratio of 22.54, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a quick ratio of 0.76, a current ratio of 1.38 and a debt-to-equity ratio of 0.59. The company’s 50-day simple moving average is $77.22 and its 200-day simple moving average is $73.28. Henry Schein has a twelve month low of $60.56 and a twelve month high of $89.29.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 24th. The company reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.04. The business had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. Henry Schein’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.19 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, research analysts predict that Henry Schein will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.